跳至主要内容
临床试验/NCT01553734
NCT01553734已完成不适用

Does Azithromycin Cause QT Prolongation in Hospitalized Patients With Severe Community Acquired Pneumonia?

HaEmek Medical Center, Israel1 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
148
试验地点
1
主要终点
Corrected QT segment of ECG

研究概览

简要总结

The macrolide group of antibiotics can cause QT prolongation, and endanger the patient with life threatening arrythmias. QT prolongation caused by Azythromycin, a relatively new macrolide, is extremely rare, and was not reported in clinical trials. Our hypothesis is that patients hospitalized with severe community acquired pneumonia, usually with multiple comorbid conditions will have a higher rate of QT prolongation, compared to the clinical trials published

详细描述

Patients hospitalized with community aquired pneumonia will have their corrected QT measured daily during antibiotic therapy. Concomittant medications and electrolyte abnormalities that cause prolonged QT will be recorded

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Severe community acquired pneumonia
  • treated with azithromycin
  • age over 18 years

排除标准

  • Azithromycin initiated before hospitalization
  • technically undecipherable ECG
  • Permanent pacemaker

结局指标

主要结局

Corrected QT segment of ECG

时间窗: Daily, at estimated peak antibiotic level, during index hospitalization

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验